C21 Investments Inc.
C21 Investments Inc. (CXXI.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cxxi.cn · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
C21 Investments Inc.You CXXI.CN | $48M | N/A | — | — |
 Cannabix Technologies Inc. BLO.CN | $75M | N/A | — | -$0.04 |
 The Cannabist Company Holdings Inc. CBST.NE | $17M | N/A | — | -$0.23 |
 Decibel Cannabis Company Inc. DB.V | $66M | N/A | — | -$0.01 |
 1CM Inc. EPIC.CN | $19M | 57.07x | — | $0.00 |
 iAnthus Capital Holdings, Inc. IAN.CN | $35M | N/A | — | -$0.01 |
 InnoCan Pharma Corporation INNO.CN | $15M | N/A | — | -$0.25 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for C21 Investments Inc. (CXXI.CN) measures how much investors pay for each dollar of the company's trailing earnings. CXXI.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.41 by its TTM earnings per share of —.
Frequently asked questions
CXXI.CN pe ratio · 6 questionsCXXI.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.41 and TTM EPS of —. Data sourced from Financial Modeling Prep via CXXI.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · C21 Investments Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10